Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD).
about
Pharmacological treatment of children with gastro-oesophageal refluxAn update on the use of pantoprazole as a treatment for gastroesophageal reflux diseaseA multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease.Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole.Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux disease.Long-term management of gastroesophageal reflux disease with pantoprazole.Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through <6 years with gastro-oesophageal reflux disease.Clinical results from a randomized, double-blind, dose-ranging study of pantoprazole in children aged 1 through 5 years with symptomatic histologic or erosive esophagitis.Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease.
P2860
Q24187847-D2A34B7C-D3A3-4DCF-BC8E-931CAEAEBB7EQ34194502-75D62F04-05BA-4B8A-BB6A-6DAB5AFD370EQ35308159-B1A217C6-EB90-4B20-BF5C-C01BE63CDA2CQ37345977-03E72DB3-CE00-4EE9-BA6D-6CF98BFAE668Q37808356-FCEA5C83-031E-482E-9A54-71E6CF17AD95Q38109860-7FB108DC-D05C-4669-9950-C2B391D34578Q38202595-460F8037-52EF-45D2-900F-2DEF467694BCQ42429093-9B42EB25-3446-416D-AEB4-4D208CCC2C60Q42608396-2C447DD1-E4D4-4BE2-A438-32B7EC28C425Q43045037-3F7FCACF-19F9-4A6E-A778-91ED8E562A8AQ47108611-B40E96A2-17DA-4ED0-9F46-D8801D693746
P2860
Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Multicenter, randomized, doubl ...... phageal reflux disease (GERD).
@en
Multicenter, randomized, doubl ...... phageal reflux disease (GERD).
@nl
type
label
Multicenter, randomized, doubl ...... phageal reflux disease (GERD).
@en
Multicenter, randomized, doubl ...... phageal reflux disease (GERD).
@nl
prefLabel
Multicenter, randomized, doubl ...... phageal reflux disease (GERD).
@en
Multicenter, randomized, doubl ...... phageal reflux disease (GERD).
@nl
P2093
P2860
P921
P356
P1433
P1476
Multicenter, randomized, doubl ...... phageal reflux disease (GERD).
@en
P2093
326 Study Group
Abdel-Hai Hammo
Elaine F Soffer
Gail M Comer
Linda Book
Robert Baker
V Marc Tsou
Wenjin Wang
P2860
P304
P356
10.1177/0009922806292792
P577
2006-10-01T00:00:00Z